![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, May 19, 2014 12:11:26 PM
Amarantus to Present at the 15th Annual B. Riley & Co. Investor Conference
Download PDF
SAN FRANCISCO, May 12, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, today announced that Gerald E. Commissiong, President and CEO will be presenting at the 15th Annual B. Riley & Co. Investor Conference in Santa Monica, CA.
Mr. Commissiong will present on Monday, May 19, 2014 at 3:30 PM PDT. His presentation will be web cast live and accessible for replay. The link to the presentation will be available on the Company's web site at www.amarantus.com.
There will be an opportunity for investors to meet one-on-one with management. Interested investors should contact the conference organizers, or our Investor Relations department at ir@amarantus.com.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM